Bruce Montgomery Joins Zymo Board
Luke Timmerman3/11/10
Bruce Montgomery, the senior vice president of Gilead Sciences in Seattle, is joining the board of directors at Seattle-based ZymoGenetics (NASDAQ: ZGEN). ZymoGenetics also said that Lars Rebien Sorensen, the CEO of Novo Nordisk, has resigned from the board. Montgomery recently led the team at Gilead that won FDA approval of a new inhalable antibiotic treatment for cystic fibrosis.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
